Primary Job Title Chairman of the Board of Directors Primary Organization 
Dun & Bradstreet
Gender Male
LinkedIn View on LinkedIn
Chris has served as a director of Dun & Bradstreet since December 2004, and is Chairman of the Nominating & Governance Committee and a member of the Compensation & Benefits Committee. Chris also served as the Lead Director from August 2010 to October 2013 when he became the Chairman of the Board.
Chris served as Executive Vice
President and Chief Financial Officer of Tyco International Ltd., a global provider of fire protection and security solutions from March 2005 until December 2010 and served as an advisor to Tyco from December 2010 until October 2012.
Previously, he served at The Interpublic Group of Companies, Inc. as Executive Vice President and Chief Operating Officer from June 2003 to December 2004, as Chief Financial Officer from August 2003 to June 2004, and as a director from July 2003 to July 2004.
Prior to that, Chris served as Executive Vice President and Chief Financial Officer of Pharmacia Corporation from 1998 to 2003, and prior to that Chris served as Executive Vice President and then President of Nabisco International, a division of Nabisco Holdings.
Chris currently serves as a Senior Advisor to McKinsey & Company and is also a director of the following public companies: Allergan plc, and Alexion Pharmaceuticals, Inc.
In the last five years he served as a director of Covidien plc., Forest Laboratories, Inc. (which was acquired by Actavis plc) and Dipexium Pharmaceuticals, Inc.
Prior to that, he served as a director of Perrigo Company, Monsanto Company and The Interpublic Group of Companies, Inc.
